The Clinical and Economic Benefits of a New Paradigm of HCV Diagnosis and Treatment

The Clinical and Economic Benefits of a New Paradigm of HCV Diagnosis and Treatment

Introduction: The current paradigm (CP) of hepatitis C virus (HCV) diagnosis and treatment in Italy’s National Health Service system has numerous steps. The European Association for the Study of the Liver recommends initiation of a pan-genotypic direct-acting antiviral regimen after a simple diagno...

Full description

Bibliographic Details
Main Authors: Stefano Fagiuoli, Matteo Ruggeri, Filipa Aragao, Rob Blissett
Format: Article
Language:English
Published: AboutScience Srl 2021-04-01
Series:Global & Regional Health Technology Assessment
Subjects:
Cost
Hepatitis C virus
Liver disease
Retention
Simplification
Online Access:https://journals.aboutscience.eu/index.php/grhta/article/view/2183

Internet

https://journals.aboutscience.eu/index.php/grhta/article/view/2183

Similar Items